Ribosome Tunnel Environment Drives the Formation of α-Helix during Cotranslational Folding
Journal of Chemical Information and Modeling · 2024
DOI: 10.1021/acs.jcim.4c00901 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2024. Verfasst von Takunori Yasuda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program in Biology, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki 305-8572, Japan. Hauptthemen laut MEDLINE: Ribosomes, Protein Folding, Protein Biosynthesis, Protein Conformation, alpha-Helical. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Doctoral Program in Biology, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki 305-8572, Japan.
- Center for Computational Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8577, Japan.
ORCID-Profile: Takunori Yasuda, Rikuri Morita, Yasuteru Shigeta, Ryuhei Harada
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yasuda, T., Morita, R., Shigeta, Y., & Harada, R. (2024). Ribosome Tunnel Environment Drives the Formation of α-Helix during Cotranslational Folding. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.4c00901
Vancouver
Yasuda T, Morita R, Shigeta Y, Harada R. Ribosome Tunnel Environment Drives the Formation of α-Helix during Cotranslational Folding. Journal of Chemical Information and Modeling. 2024. doi:10.1021/acs.jcim.4c00901
BibTeX
@article{Yasuda2024,
author = {Yasuda, Takunori and Morita, Rikuri and Shigeta, Yasuteru and Harada, Ryuhei},
title = {Ribosome Tunnel Environment Drives the Formation of α-Helix during Cotranslational Folding},
journal = {Journal of Chemical Information and Modeling},
year = {2024},
doi = {10.1021/acs.jcim.4c00901}
}
EUVIMED